The News
Sofinnova Partners annonces the successful stock market flotations of two portfolio companies
05/10/2005
Esmertec floated on the SWX Swiss Exchange, raising CHF 98 million (€63 million), Vistaprint floated on NASDAQ, raising $ 120 million (€100 million).
Paris, 5 October 2005 – Sofinnova Partners is pleased to announce that two of its portfolio companies in information technology have successfully completed their IPOs, raising a total of €160 million. These stock market flotations validate Sofinnova Partners’ preferred investment model, which consists of financing and actively assisting companies from the very start all the way through expansion to an exit that allows them to remain independent leaders in their markets.
Esmertec, a world leader in Java embedded software solutions for mobile phones, PDAs, and consumer electronics devices, was floated on the SWX Swiss Exchange on September 29, raising CHF 98 million (€63 million). Based in Dubendorf, near Zürich, Esmertec currently trades at a market valuation of CHF 290 million (€187 million). The IPO will allow the company to strengthen its worldwide leadership position in its market.
Sofinnova Partners has been an active co-lead investor in Esmertec since early 2002. It has helped the company grow internationally from less than million in revenues in 2001 to more than million for the first half of this year by bringing in top management talent and by identifying and assessing new acquisition opportunities in the US and in Asia. “Esmertec’s management, actively supported by its investors and board members, has managed to acquire five companies in three years, to gain impressive market share, and to achieve profitability while growing at a tremendous rate,” says Jean Schmitt, Managing Partner at Sofinnova Partners. “Together, we have turned a European technology start-up into a global leader with more than 250 employees and most of its revenues coming from Asia.”
Vistaprint, an international e-printing services company, was floated on NASDAQ on September 30, raising million in a $ 120 million offering. Vistaprint’s share price rose by 27% on the first day of trading, giving the company a market capitalization of $ 600 million. With its US headquarters in Boston, Vistaprint is a world leader in on-line graphic design and printing services. Sofinnova Partners seed-financed the company when it was set up in Paris in 1997. Since then, Sofinnova has been pro-active in developing an internet-only business model, which has proved to be highly successful and profitable, and in helping the company to grow internationally. “When we funded Vistaprint, the company consisted of one American guy with a French colleague in a small, cramped office,” says Olivier Protard, Managing Partner at Sofinnova Partners. “Few venture capitalists were interested in on-line printing at the time, but we had big ambitions for the company from the start. We believed we could revolutionize the printing industry – and that has turned out to be the case.”
“The successful IPOs of both Esmertec and Vistaprint show that at Sofinnova Partners we make money the hard way – by actively accompanying our portfolio companies over the long term from young technology start-ups to world leaders in their fields,” says Jean-Bernard Schmidt, Managing Partner and Chairman.
For further information, please contact:
Madeleine Resener
Media Relations
Sofinnova Partners
Tel: +33 (0) 6 20 41 39 82
mresener@sofinnova.fr
About Sofinnova Partners
Founded in Paris in 1972, Sofinnova Partners is one of Europe's leading independent venture capital firms. With €900 million under management, Sofinnova Partners invests in start-ups and early-stage companies in information technology and life sciences. Its investment strategy consists of investing early in teams and projects with high potential, most often acting as lead or co-lead investor. Sofinnova Partners also benefits from a long-established relationship with its sister company in San Francisco, Sofinnova Ventures. Sofinnova Partners’ team consists of 10 professionals who bring valuable market insight and technical expertise to portfolio companies.
2005
- 03/01/2005
- 01/01/2005
- 05/01/2005
- 10/01/2005
- 17/01/2005
- 17/01/2005
- 19/01/2005
- 27/01/2005
-
27/01/2005
XYOTAXTM Pivotal Trial in Non-Small Cell Lung Cancer, STELLAR 3, Reaches Required Number of Events
-
28/01/2005
Esmertec and MontaVista Software to deliver integrated Java-Linux solutions for mobile phones
-
28/01/2005
Esmertec et MontaVista Software proposent des solutions Java-Linux intégrées pour terminaux Mobiles
- 02/02/2005
-
02/02/2005
Esmertec acquiert la Division Mobile de CoreTek Systems, en Chine
- 07/02/2005
- 07/02/2005
-
08/02/2005
XYOTAX Patent Allowance Provides Exclusivity in Europe Until 2017
-
08/02/2005
WebSideStory Announces Agreement to Acquire Atomz and Launch of Active Marketing Suite
-
16/02/2005
Important soutien financier en faveur des recherches sur le cancer de DIATOS N.V.
-
16/02/2005
DIATOS N.V.’s oncology research boosted by significant funding
- 22/02/2005
- 22/02/2005
- 08/03/2005
-
10/03/2005
Sofinnova Parners voted European VC Firm of the year in Global Private Equity Awards
-
10/03/2005
Sofinnova Parners voted European VC Firm of the year in Global Private Equity Awards
- 16/03/2005
-
16/03/2005
Varioptic to demonstrate the world's first liquid zoom lens for camera phones at Cebit
- 15/03/2005
- 17/03/2005
-
22/03/2005
CoTherix's Ventavis(R) Commercially Available for the Treatment of Pulmonary Arterial Hypertension
-
22/03/2005
CoTherix's Ventavis(R) Commercially Available for the Treatment of Pulmonary Arterial Hypertension
- 24/03/2005
-
24/03/2005
Nomination de Jean Schmitt comme Partenaire-Associé chez Sofinnova Partners
- 24/03/2005
- 24/03/2005
- 06/04/2005
- 06/04/2005
- 08/04/2005
- 08/04/2005
- 04/04/2005
-
12/04/2005
Neuro3d Reports Positive Results from Phase II Trials of Ocaperidone in Schizophrenia
-
12/04/2005
Diatos S.A. opens its US subsidiary in California - Diatos USA, Inc.
- 14/04/2005
-
26/04/2005
GPC Biotech and Ingenium Receive € 2.2 Million Joint Drug Discovery Grant from German Ministry
-
26/04/2005
GPC Biotech and Ingenium Receive € 2.2 Million Joint Drug Discovery Grant from German Ministry
- 12/05/2005
-
12/05/2005
6WIND announces R&D partnership with China academy of science
- 16/05/2005
- 16/05/2005
-
16/05/2005
New Ventavis(R) Data to Be Presented at American Thoracic Society's International Conference
-
16/05/2005
New Ventavis(R) Data to Be Presented at American Thoracic Society's International Conference
-
17/05/2005
DIATOS and SERVIER announce oncology research collaboration using the VECTOCELL® technology
-
17/05/2005
DIATOS and SERVIER announce oncology research collaboration using the VECTOCELL® technology
-
17/05/2005
DIATOS S.A. opens its US subsidiary in California – DIATOS USA, INC.
-
17/05/2005
DIATOS S.A. opens its US subsidiary in California – DIATOS USA, INC.
- 19/05/2005
- 23/05/2005
- 19/05/2005
- 23/05/2005
- 23/05/2005
- 23/05/2005
-
07/06/2005
OXXIUS Shrinks DPSS Lasers and announces world’s smallest blue laser module
-
07/06/2005
OXXIUS Shrinks DPSS Lasers and announces world’s smallest blue laser module
- 20/06/2005
-
20/06/2005
Sofinnova Partners investit 4 millions d'euros dans Endotis Pharma
- 14/06/2005
- 14/06/2005
-
27/06/2005
Esmertec et LG Electronics présentent un mobile doté d’une JVM (Java Virtual Machine) multi-tâches
-
27/06/2005
Esmertec and LG Electronics Demonstrate Multi-tasking Java Virtual Machine on a Mobile Handset
-
28/06/2005
Revolt technology receives €7 million in first round of financing
- 05/07/2005
- 08/07/2005
-
06/07/2005
Esmertec officially opened its R&D and Customer Support Center in Chengdu, China
- 28/07/2005
- 22/08/2005
-
16/08/2005
Epimmune and IDM S.A. Join Forces to become IDM Pharma, Inc.
-
16/08/2005
Epimmune et IDM S.A. fusionnent pour devenir IDM PHARMA, INC.
-
25/07/2005
UPEK® provides Biometric Finger security for the THINKPAD* Tablet
-
21/07/2005
InfraWorlds acquiert 995 SOFT et entre sur le marché américain
-
25/07/2005
Infraworlds crée un nouveau format de jeu grand public : SagaZ
- 25/07/2005
-
03/08/2005
Infraworlds creates SagaZ, a new game format for the mass market
- 26/07/2005
- 28/07/2005
- 22/08/2005
- 22/08/2005
- 30/08/2005
-
31/08/2005
NEC Infrontia fait de Jbed CDC, la plate-forme Java d’Esmertec, son standard JVM
- 31/08/2005
-
06/09/2005
Varioptic expands its focus to deliver liquid lenses in new markets
- 26/09/2005
-
30/09/2005
VoluBill announces “Charge it” – a comprehensive mobile data charging solution
- 03/10/2005
- 30/09/2005
-
05/10/2005
Sofinnova Partners annonces the successful stock market flotations of two portfolio companies
- 17/10/2005
- 25/10/2005
- 20/10/2005
- 07/11/2005
- 14/11/2005
- 10/11/2005
-
23/09/2005
Servista wins "BPO Service Provider of the Year" at NOA awards ceremony 2005
- 15/11/2005
-
22/11/2005
Tsinghua Tongfang and 6Wind partnership to take China's booming ICT market by storm
-
22/11/2005
Tsingha Tongfang et 6Wind à la conquête du marché chinois des TIC
-
17/11/2005
6Wind contributes to success of KDDI's mobile broadband project
-
17/11/2005
6Wind contribue au succès du projet de réseau mobile haut débit mené par l'opérateur japonnais KDDI
- 21/11/2005
-
21/11/2005
Howard Ford former Managing Director of Equant joins Varioptic as Chairman of the Board Lyon, France
- 19/10/2005
- 24/11/2005
- 06/12/2005
-
13/12/2005
CoTherix and Respironics Announce Launch of New Portable Inhalation Device to Ventavis Patients
- 13/12/2005
- 13/12/2005
-
14/12/2005
Professor Peter Van Brummelen and DR. Annick Schwebig join the board of directors of Diatos S.A.
- 29/11/2005
- 26/12/2005
- 23/12/2005